4//SEC Filing
Gold Lawrence Marshall 4
Accession 0001213900-23-074490
CIK 0001690080other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 6:53 PM ET
Size
8.0 KB
Accession
0001213900-23-074490
Insider Transaction Report
Form 4
Gold Lawrence Marshall
Director
Transactions
- Award
Common Stock
2023-09-04+21,455→ 24,745 total - Award
Non-Qualified Stock Option (right to buy)
2023-09-04+15,000→ 15,000 totalExercise: $0.67Exp: 2033-09-04→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]Issued in consideration for serving on the Board of Directors, as a Member of the Audit and Compensation Committee of the Board of Directors, and as Chairman of the Nominating and Corporate Governance Committee of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
- [F2]Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
- [F3]The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001355868
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 6:53 PM ET
- Size
- 8.0 KB